INFORM

A sample collection to facilitate the performance evaluation of the LumiraDX point of care device for the detection of Influenza  A/B, Respiratory Syncytial Virus (RVS) & SARS-COV-2 Virus

This is a sample collection protocol in a population of patients attending their designated care or testing facility
suspected of having a respiratory illness typical of Influenza, RSV or COVID-19 (coughing, wheezing, high
temperature etc.

Primary objective – Collection of Nasal Swabs (NS), Throat Swabs (TS) and Saliva Samples positive for
Influenza A, Influenza B, RSV or SARS-CoV-2 across a range of demographics.

Sample size – 1500 participants over the duration of the Influenza, RSV and predicted Covid-19 season in the UK.

More information to follow shortly.

Status: coming-soon

Start Date

TBC

Chief Investigator

Dr. Jen Browning

Main Trial Site

Royal Infirmary of Edinburgh and the the Royal Hospital for Children and Young People